Marché européen des tests au point de service (POCT) – Tendances et prévisions du secteur jusqu’en 2029

Analyse et perspectives du marché européen des tests au point de service (POCT)

Les tests au point de service (POCT) sont des tests qui peuvent être effectués à proximité immédiate du patient, où une décision médicale peut être prise immédiatement, y compris les résultats et le suivi. La prévalence accrue des maladies infectieuses et chroniques, l'amélioration du taux de recherche de diagnostic et la préférence croissante pour les tests à domicile sont quelques-uns des principaux moteurs de la croissance du marché.

Cependant, le manque d’alignement avec les résultats des tests obtenus en laboratoire, le coût élevé et le manque de personnel formé sont quelques-uns des défis qui entravent la croissance du marché.

Le marché européen des tests au point de service (POCT) devrait connaître une croissance du marché au cours de la période de prévision de 2022 à 2029. Data Bridge Market Research analyse que le marché croît avec un TCAC de 8,8 % au cours de la période de prévision de 2022 à 2029 et devrait atteindre 13 085,33 millions USD d'ici 2029.

Définition du marché

Point of Care Testing (POCT) is also called with-patient testing and allows physicians to accurately measure real-time, lab-quality diagnostic results within a few minutes as compared to hours. Currently, there are various products available that provide rapid and accurate results and help in patient’s better outcomes which is expected to provide various other opportunities for the market growth. However, lack of alignment in lab results and high cost of POCT products are expected to restrain the market growth in the forecast period.

Europe point of care testing (POCT) market report provides details of market share, new developments, product pipeline analysis and impact of domestic and localized market players that analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Point of Care Testing (POCT) Market Dynamics

Drivers

• Increasing prevalence of infectious and chronic diseases

The prevalence of infectious and chronic diseases such as cancer, diabetes and cardiovascular disorder is rapidly increasing across Europe. According to the World Health Organization (WHO), the contribution of chronic diseases was about 60% which accounted for the number of deaths. In Europe, the major reason behind the increasing number of chronic diseases is the increasing number of geriatric population. These increasing rates of the diseases are directly proportional to the market growth of POCT devices as they are used in the diagnosis of almost all diseases. We also know that as health degeneration begins with aging, the rate of chronic diseases and factors associated with them also increase with time. However, with increase in disease rate, the healthcare system and status of health is also improving due to awareness and adoption of POCT devices that help in the diagnosis of multiple chronic diseases thereby, driving the market growth.

For instance,

• In October 2017, according to a report published in Springer, 85% of deaths in the European Union (EU) were due to chronic diseases including cancer, cardiovascular disease, chronic respiratory disease, diabetes and mental illness

The growing incidences of chronic diseases in Europe with conditions like cancer, asthma and heart disease among others have improved the usage and awareness about early diagnosis of diseases. This awareness made people buy more healthcare premiums including whole body check-ups regularly that includes almost all the tests. At the same time, the population of chronic diseases is rapidly increasing.

 Thus, a major surge in the prevalence of chronic diseases will be acting as a major driver for the market growth as POCT devices can effectively manage the disorder and provide better comfort and treatment for monitoring whenever needed.

• Improved diagnosis-seeking rate

Improved healthcare professionals and regular training sessions for the professionals conducting tests have contributed to the improved diagnosis rates in the region, which includes an increase in the successful diagnosis of chronic diseases like cancer, cardiovascular disease, type 2 diabetes and others. The rate of diagnosis also increases as the burden of disease increases. Healthcare and IT professionals have the power to decrease the likelihood of error and are making attempts to increase the rate of seeking POCT. Along with that, they also help in determining and detecting the risk associated with it. Perhaps, to improve the rate of diagnosis the IT professionals evaluate the user experience also.

To support the POCT process, a methodology was introduced that includes coverage of management, time spent by professionals for diagnosis and evaluation activities that would help in improving the accuracy rate of the information and help in making better decisions in terms of diagnosis. Thus, the efforts by the healthcare and IT professionals, improved training of healthcare professionals, change in the patient care delivery system and improved diagnosis-seeking rate in the region are leading to the market growth.

• Rising preference for homecare testing

Increased demand for homecare testing results in reduced error and safety with ensured quality clinical information that will be available at appropriate time and location and also helps to understand the elder case of a medical emergency. The market has been growing due to rising geriatric population thereby, increasing the demand for homecare testing. With the help of cutting-edge modern technologies, home health care costs have been dramatically reduced and people are being helped effectively. Thus, increased preferences for home healthcare services will boost the demand for POCT devices driving the market growth.

Opportunity

• Strategic initiatives by the market players

The increase in the prevalence of chronic and infectious diseases in Europe requires new and advanced POCT kits and solutions with improved efficacy rate and reduced cycle time due to rise in the geriatric population and also to improve the healthcare management and diagnostics for quality performance. Major market leaders are engaged in full filling the demands of healthcare professionals and spending their time in research to produce better products, kits and reagents.

These strategic initiatives by the companies including acquisition and focused segment product launches are helping them to expand and enhance the product portfolio of the company which will ultimately lead to more revenue generation. Hence, these strategic initiatives by the market players are acting as an opportunity that is helping them to drive market growth.

Restraint/Challenge

• Lack of alignment with test results obtained from laboratories

The POCT results when compared with laboratory testing standards can differ and be performed by clinical personnel who are not trained in clinical laboratory sciences. The standardization and other essential criteria cannot be completed by POCT and this is acting as a major challenge for the market growth.

Given the advantages of POCT research, some downsides are not necessarily considered the safest choice. Owing to the sensitivity and precision associated with laboratory analyzers, clinical laboratory personnel are well aware of the analytical methodologies and are more reliable. In comparison, the test carried out by healthcare personnel rather than laboratory qualified persons resulted in mistakes arising from lack of awareness on the significance of quality management and quality assurance procedures. Thus, more precise and accurate results can be expected from laboratory testing as POCT faces challenges to meet all specific standards of testing due to lack of knowledge.

Recent Developments

• In May 2022, Abbott updated i-STAT software for hospitals and outpatient facilities to provide solution in real-time. The software consists of high efficacy rate, is cost-effective and provides good quality patient care decision-making
• In May 2022, EKF Diagnostics announced the launch of its new EKF Link digital connectivity solution for the secure management of POC analyzers and associated data on one centralized platform

Europe Point of Care Testing (POCT) Market Scope

Europe point of care testing (POCT) market is segmented into product, application, end user, mode of testing and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

• Instruments
• Consumables & Reagents
• Others

Based on product, the market is segmented into instruments, consumables & reagents and others.

Application

• Blood Glucose
• Cardiac Monitoring
• Coagulation
• Whole Blood Analysis
• Vital Sign Monitoring
• Infectious Disease Testing
• Urine Analysis
• Cholesterol Testing
• Others

Based on application, the market is segmented into blood glucose, cardiac monitoring, coagulation, whole blood analysis, vital sign monitoring, infectious disease testing, urine analysis, cholesterol testing and others.

End User

• Laboratories
• Hospitals
• Clinics
• Ambulatory Centers
• Home Care
• Assisted Living Facilities
• Pharmacies/Drug Stores
• Others

En fonction de l'utilisateur final, le marché est segmenté en laboratoires, hôpitaux, cliniques, centres ambulatoires, soins à domicile, résidences pour personnes âgées assistées, pharmacies/parapharmacies et autres.

Mode de test

• Tests sur ordonnance
• Tests en vente libre

En fonction du mode de test, le marché est segmenté en tests sur ordonnance et en tests en vente libre.

 Canal de distribution

• Vente directe
• Distributeur tiers
• Vente en ligne

En fonction du canal de distribution, le marché est segmenté en ventes directes, distributeurs tiers et vente en ligne.

Analyse/perspectives régionales du marché européen des tests au point de service (POCT)      

Le marché européen des tests au point de service (POCT) est analysé et des informations sur la taille du marché et les tendances sont fournies par produit, application, utilisateur final, mode de test et canal de distribution.

Les pays couverts par ce marché sont l'Allemagne, la France, le Royaume-Uni, l'Italie, l'Espagne, les Pays-Bas, la Russie, la Suisse, la Turquie, la Belgique et le reste de l'Europe. L'Allemagne domine le marché européen des tests au point de service (POCT) en termes de part de marché et de chiffre d'affaires et continuera à accroître sa domination au cours de la période de prévision. Cela est dû à la sensibilisation accrue aux appareils POCT dans la région Europe.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données, tels que les ventes de produits neufs et de remplacement, la démographie des pays, l'épidémiologie des maladies et les tarifs d'importation et d'exportation, sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la forte concurrence des marques locales et nationales et de l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.

Analyse du paysage concurrentiel et des parts de marché des tests au point de service (POCT) en Europe

Le paysage concurrentiel du marché des tests au point de service fournit des détails par concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises sur le marché des tests au point de service.

Français Certains des principaux acteurs opérant sur ce marché sont Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Quidel Corporation Trividia Health, Inc., Nova Biomedical, PTS Diagnostics, Trinity Biotech, LumiraDx, Sekisui Diagnostics, Chembio Diagnostics, Inc., BD, Thermo Fisher Scientific Inc., Abbott, Danaher, binx health, Inc., QuantuMDx Group Ltd., Werfen, Thermo Fisher Scientific, Abaxis, EKF Diagnostics et Sysmex Europe SE, entre autres.

SKU-33910